Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sonoma Pharmaceuticals, Inc.

3.32
-0.0500-1.48%
Post-market: 3.320.00000.00%19:39 EDT
Volume:30.35K
Turnover:101.32K
Market Cap:5.36M
PE:-0.91
High:3.41
Open:3.41
Low:3.30
Close:3.37
Loading ...

Crude Oil Falls Over 3%; Philip Morris Earnings Top Views

Benzinga
·
24 Apr

Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket

Benzinga
·
23 Apr

Sonoma Pharmaceuticals Poised to Sell Acne Products in UK; Shares Soar Premarket

MT Newswires Live
·
23 Apr

Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

ACCESS Newswire
·
23 Apr

Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain

Zacks
·
27 Mar

Delaware passes law designed to stop more Elon Musks from leaving state

Yahoo Finance
·
27 Mar

Wall Street Stabilizes, Driving Quiet Premarket Action for US Equity Futures

MT Newswires Live
·
11 Mar

Why Fast-paced Mover Sonoma Pharmaceuticals (SNOA) Is a Great Choice for Value Investors

Zacks
·
11 Mar

Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)

ACCESS Newswire
·
11 Mar

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

ACCESS Newswire
·
26 Feb

More Musk-like 'Dexits' pose fresh threat to Delaware's corporation crown

Yahoo Finance
·
15 Feb

Sonoma Pharmaceuticals Third Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
07 Feb

Sonoma Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
07 Feb

Sonoma Pharmaceuticals Q3 2025 GAAP EPS $(0.63) Beats $(0.69) Estimate, Sales $3.564 Miss $4.060M Estimate

Benzinga
·
06 Feb

Sonoma Pharmaceuticals Inc expected to post a loss of 69 cents a share - Earnings Preview

Reuters
·
05 Feb